PIER 88 INVESTMENT PARTNERS LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 280 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
PIER 88 INVESTMENT PARTNERS LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$469,812
+38.4%
58,580
+155.8%
0.10%
+26.5%
Q1 2024$339,378
+53.0%
22,900
-16.1%
0.08%
+48.2%
Q4 2023$221,868
+35.3%
27,290
+310.4%
0.06%
+14.3%
Q3 2021$164,000
+290.5%
6,650
+310.5%
0.05%
+308.3%
Q2 2021$42,000
-92.3%
1,620
-90.6%
0.01%
-93.5%
Q1 2021$549,000
-42.3%
17,326
-15.4%
0.19%
-39.2%
Q4 2020$951,000
-28.7%
20,491
-49.4%
0.31%
-24.3%
Q3 2020$1,333,000
+332.8%
40,481
+260.6%
0.40%
+359.1%
Q2 2020$308,000
+12.0%
11,225
+22.1%
0.09%
-12.0%
Q1 2020$275,0009,1900.10%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,019,201$26,720,00020.38%
Broadfin Capital, LLC 5,951,153$52,668,0006.92%
GREAT POINT PARTNERS LLC 5,567,348$49,271,0006.23%
Avoro Capital Advisors LLC 10,261,039$90,810,0005.43%
FRAZIER MANAGEMENT LLC 2,188,331$19,367,0005.00%
Prosight Management, LP 1,062,500$9,403,0004.85%
Perceptive Advisors 12,241,111$108,333,0004.12%
Ghost Tree Capital, LLC 1,000,000$8,850,0003.21%
QVT Financial LP 1,021,361$8,696,0002.84%
Vivo Capital, LLC 1,600,000$14,160,0001.81%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders